Global HER2 Tumor Marker Testing Supply, Demand and Key Producers, 2023-2029
The global HER2 Tumor Marker Testing market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).
The global market for HER2 Tumor Marker Testing has been experiencing steady growth. This growth is primarily driven by the increasing incidence of breast cancer and the importance of HER2 status in determining treatment decisions. The market size is influenced by factors such as population aging, awareness of breast cancer screening, and advancements in diagnostic techniques. North America, particularly the United States, is a significant market for HER2 Tumor Marker Testing. The region has well-established breast cancer screening and diagnosis programs. The adoption of targeted therapies, such as Herceptin, has been prominent in this region. Europe also has a substantial market for HER2 testing, with countries like the United Kingdom, Germany, and France being key contributors. The European market is characterized by a growing emphasis on early cancer detection and personalized medicine. The Asia-Pacific region, including countries like China and India, offers growth opportunities. The increasing healthcare spending, growing awareness of breast cancer, and rising population contribute to market expansion.
HER2 Tumor Marker Testing is a diagnostic test used in oncology to assess the status of the HER2 gene and the presence of HER2 protein receptors in breast cancer and some other types of cancer, such as gastric (stomach) cancer. HER2 stands for Human Epidermal Growth Factor Receptor 2, which is a gene that encodes a protein receptor on the surface of certain cells, including breast cells. HER2 status is an important factor in determining treatment options and predicting the prognosis for individuals with specific types of cancer.
This report studies the global HER2 Tumor Marker Testing demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for HER2 Tumor Marker Testing, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of HER2 Tumor Marker Testing that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global HER2 Tumor Marker Testing total market, 2018-2029, (USD Million)
Global HER2 Tumor Marker Testing total market by region & country, CAGR, 2018-2029, (USD Million)
U.S. VS China: HER2 Tumor Marker Testing total market, key domestic companies and share, (USD Million)
Global HER2 Tumor Marker Testing revenue by player and market share 2018-2023, (USD Million)
Global HER2 Tumor Marker Testing total market by Type, CAGR, 2018-2029, (USD Million)
Global HER2 Tumor Marker Testing total market by Application, CAGR, 2018-2029, (USD Million).
This reports profiles major players in the global HER2 Tumor Marker Testing market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Abbott, Roche, Thermo Fisher Scientific, Agilent, Leica Biosystems, Biocare Medical, BioGenex, Sysmex and Abnova, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World HER2 Tumor Marker Testing market.
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global HER2 Tumor Marker Testing Market, By Region:
1. How big is the global HER2 Tumor Marker Testing market?
2. What is the demand of the global HER2 Tumor Marker Testing market?
3. What is the year over year growth of the global HER2 Tumor Marker Testing market?
4. What is the total value of the global HER2 Tumor Marker Testing market?
5. Who are the major players in the global HER2 Tumor Marker Testing market?
The global market for HER2 Tumor Marker Testing has been experiencing steady growth. This growth is primarily driven by the increasing incidence of breast cancer and the importance of HER2 status in determining treatment decisions. The market size is influenced by factors such as population aging, awareness of breast cancer screening, and advancements in diagnostic techniques. North America, particularly the United States, is a significant market for HER2 Tumor Marker Testing. The region has well-established breast cancer screening and diagnosis programs. The adoption of targeted therapies, such as Herceptin, has been prominent in this region. Europe also has a substantial market for HER2 testing, with countries like the United Kingdom, Germany, and France being key contributors. The European market is characterized by a growing emphasis on early cancer detection and personalized medicine. The Asia-Pacific region, including countries like China and India, offers growth opportunities. The increasing healthcare spending, growing awareness of breast cancer, and rising population contribute to market expansion.
HER2 Tumor Marker Testing is a diagnostic test used in oncology to assess the status of the HER2 gene and the presence of HER2 protein receptors in breast cancer and some other types of cancer, such as gastric (stomach) cancer. HER2 stands for Human Epidermal Growth Factor Receptor 2, which is a gene that encodes a protein receptor on the surface of certain cells, including breast cells. HER2 status is an important factor in determining treatment options and predicting the prognosis for individuals with specific types of cancer.
This report studies the global HER2 Tumor Marker Testing demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for HER2 Tumor Marker Testing, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of HER2 Tumor Marker Testing that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global HER2 Tumor Marker Testing total market, 2018-2029, (USD Million)
Global HER2 Tumor Marker Testing total market by region & country, CAGR, 2018-2029, (USD Million)
U.S. VS China: HER2 Tumor Marker Testing total market, key domestic companies and share, (USD Million)
Global HER2 Tumor Marker Testing revenue by player and market share 2018-2023, (USD Million)
Global HER2 Tumor Marker Testing total market by Type, CAGR, 2018-2029, (USD Million)
Global HER2 Tumor Marker Testing total market by Application, CAGR, 2018-2029, (USD Million).
This reports profiles major players in the global HER2 Tumor Marker Testing market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Abbott, Roche, Thermo Fisher Scientific, Agilent, Leica Biosystems, Biocare Medical, BioGenex, Sysmex and Abnova, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World HER2 Tumor Marker Testing market.
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global HER2 Tumor Marker Testing Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- Immunohistochemistry (IHC)
- Fluorescence In Situ Hybridization (FISH)
- Silver In Situ Hybridization (SISH)
- Others
- Hospitals
- Diagnostic Laboratories
- Others
- Abbott
- Roche
- Thermo Fisher Scientific
- Agilent
- Leica Biosystems
- Biocare Medical
- BioGenex
- Sysmex
- Abnova
- Novartis
- InvivoGen
1. How big is the global HER2 Tumor Marker Testing market?
2. What is the demand of the global HER2 Tumor Marker Testing market?
3. What is the year over year growth of the global HER2 Tumor Marker Testing market?
4. What is the total value of the global HER2 Tumor Marker Testing market?
5. Who are the major players in the global HER2 Tumor Marker Testing market?
1 SUPPLY SUMMARY
1.1 HER2 Tumor Marker Testing Introduction
1.2 World HER2 Tumor Marker Testing Market Size & Forecast (2018 & 2022 & 2029)
1.3 World HER2 Tumor Marker Testing Total Market by Region (by Headquarter Location)
1.3.1 World HER2 Tumor Marker Testing Market Size by Region (2018-2029), (by Headquarter Location)
1.3.2 United States HER2 Tumor Marker Testing Market Size (2018-2029)
1.3.3 China HER2 Tumor Marker Testing Market Size (2018-2029)
1.3.4 Europe HER2 Tumor Marker Testing Market Size (2018-2029)
1.3.5 Japan HER2 Tumor Marker Testing Market Size (2018-2029)
1.3.6 South Korea HER2 Tumor Marker Testing Market Size (2018-2029)
1.3.7 ASEAN HER2 Tumor Marker Testing Market Size (2018-2029)
1.3.8 India HER2 Tumor Marker Testing Market Size (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 HER2 Tumor Marker Testing Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 HER2 Tumor Marker Testing Major Market Trends
2 DEMAND SUMMARY
2.1 World HER2 Tumor Marker Testing Consumption Value (2018-2029)
2.2 World HER2 Tumor Marker Testing Consumption Value by Region
2.2.1 World HER2 Tumor Marker Testing Consumption Value by Region (2018-2023)
2.2.2 World HER2 Tumor Marker Testing Consumption Value Forecast by Region (2024-2029)
2.3 United States HER2 Tumor Marker Testing Consumption Value (2018-2029)
2.4 China HER2 Tumor Marker Testing Consumption Value (2018-2029)
2.5 Europe HER2 Tumor Marker Testing Consumption Value (2018-2029)
2.6 Japan HER2 Tumor Marker Testing Consumption Value (2018-2029)
2.7 South Korea HER2 Tumor Marker Testing Consumption Value (2018-2029)
2.8 ASEAN HER2 Tumor Marker Testing Consumption Value (2018-2029)
2.9 India HER2 Tumor Marker Testing Consumption Value (2018-2029)
3 WORLD HER2 TUMOR MARKER TESTING COMPANIES COMPETITIVE ANALYSIS
3.1 World HER2 Tumor Marker Testing Revenue by Player (2018-2023)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global HER2 Tumor Marker Testing Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for HER2 Tumor Marker Testing in 2022
3.2.3 Global Concentration Ratios (CR8) for HER2 Tumor Marker Testing in 2022
3.3 HER2 Tumor Marker Testing Company Evaluation Quadrant
3.4 HER2 Tumor Marker Testing Market: Overall Company Footprint Analysis
3.4.1 HER2 Tumor Marker Testing Market: Region Footprint
3.4.2 HER2 Tumor Marker Testing Market: Company Product Type Footprint
3.4.3 HER2 Tumor Marker Testing Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers, Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF THE WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: HER2 Tumor Marker Testing Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: HER2 Tumor Marker Testing Market Size Comparison (2018 & 2022 & 2029) (by Headquarter Location)
4.1.2 United States VS China: HER2 Tumor Marker Testing Revenue Market Share Comparison (2018 & 2022 & 2029)
4.2 United States Based Companies VS China Based Companies: HER2 Tumor Marker Testing Consumption Value Comparison
4.2.1 United States VS China: HER2 Tumor Marker Testing Consumption Value Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: HER2 Tumor Marker Testing Consumption Value Market Share Comparison (2018 & 2022 & 2029)
4.3 United States Based HER2 Tumor Marker Testing Companies and Market Share, 2018-2023
4.3.1 United States Based HER2 Tumor Marker Testing Companies, Headquarters (States, Country)
4.3.2 United States Based Companies HER2 Tumor Marker Testing Revenue, (2018-2023)
4.4 China Based Companies HER2 Tumor Marker Testing Revenue and Market Share, 2018-2023
4.4.1 China Based HER2 Tumor Marker Testing Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies HER2 Tumor Marker Testing Revenue, (2018-2023)
4.5 Rest of World Based HER2 Tumor Marker Testing Companies and Market Share, 2018-2023
4.5.1 Rest of World Based HER2 Tumor Marker Testing Companies, Headquarters (States, Country)
4.5.2 Rest of World Based Companies HER2 Tumor Marker Testing Revenue, (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World HER2 Tumor Marker Testing Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Immunohistochemistry (IHC)
5.2.2 Fluorescence In Situ Hybridization (FISH)
5.2.3 Silver In Situ Hybridization (SISH)
5.2.4 Others
5.3 Market Segment by Type
5.3.1 World HER2 Tumor Marker Testing Market Size by Type (2018-2023)
5.3.2 World HER2 Tumor Marker Testing Market Size by Type (2024-2029)
5.3.3 World HER2 Tumor Marker Testing Market Size Market Share by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World HER2 Tumor Marker Testing Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Hospitals
6.2.2 Diagnostic Laboratories
6.2.3 Others
6.3 Market Segment by Application
6.3.1 World HER2 Tumor Marker Testing Market Size by Application (2018-2023)
6.3.2 World HER2 Tumor Marker Testing Market Size by Application (2024-2029)
6.3.3 World HER2 Tumor Marker Testing Market Size by Application (2018-2029)
7 COMPANY PROFILES
7.1 Abbott
7.1.1 Abbott Details
7.1.2 Abbott Major Business
7.1.3 Abbott HER2 Tumor Marker Testing Product and Services
7.1.4 Abbott HER2 Tumor Marker Testing Revenue, Gross Margin and Market Share (2018-2023)
7.1.5 Abbott Recent Developments/Updates
7.1.6 Abbott Competitive Strengths & Weaknesses
7.2 Roche
7.2.1 Roche Details
7.2.2 Roche Major Business
7.2.3 Roche HER2 Tumor Marker Testing Product and Services
7.2.4 Roche HER2 Tumor Marker Testing Revenue, Gross Margin and Market Share (2018-2023)
7.2.5 Roche Recent Developments/Updates
7.2.6 Roche Competitive Strengths & Weaknesses
7.3 Thermo Fisher Scientific
7.3.1 Thermo Fisher Scientific Details
7.3.2 Thermo Fisher Scientific Major Business
7.3.3 Thermo Fisher Scientific HER2 Tumor Marker Testing Product and Services
7.3.4 Thermo Fisher Scientific HER2 Tumor Marker Testing Revenue, Gross Margin and Market Share (2018-2023)
7.3.5 Thermo Fisher Scientific Recent Developments/Updates
7.3.6 Thermo Fisher Scientific Competitive Strengths & Weaknesses
7.4 Agilent
7.4.1 Agilent Details
7.4.2 Agilent Major Business
7.4.3 Agilent HER2 Tumor Marker Testing Product and Services
7.4.4 Agilent HER2 Tumor Marker Testing Revenue, Gross Margin and Market Share (2018-2023)
7.4.5 Agilent Recent Developments/Updates
7.4.6 Agilent Competitive Strengths & Weaknesses
7.5 Leica Biosystems
7.5.1 Leica Biosystems Details
7.5.2 Leica Biosystems Major Business
7.5.3 Leica Biosystems HER2 Tumor Marker Testing Product and Services
7.5.4 Leica Biosystems HER2 Tumor Marker Testing Revenue, Gross Margin and Market Share (2018-2023)
7.5.5 Leica Biosystems Recent Developments/Updates
7.5.6 Leica Biosystems Competitive Strengths & Weaknesses
7.6 Biocare Medical
7.6.1 Biocare Medical Details
7.6.2 Biocare Medical Major Business
7.6.3 Biocare Medical HER2 Tumor Marker Testing Product and Services
7.6.4 Biocare Medical HER2 Tumor Marker Testing Revenue, Gross Margin and Market Share (2018-2023)
7.6.5 Biocare Medical Recent Developments/Updates
7.6.6 Biocare Medical Competitive Strengths & Weaknesses
7.7 BioGenex
7.7.1 BioGenex Details
7.7.2 BioGenex Major Business
7.7.3 BioGenex HER2 Tumor Marker Testing Product and Services
7.7.4 BioGenex HER2 Tumor Marker Testing Revenue, Gross Margin and Market Share (2018-2023)
7.7.5 BioGenex Recent Developments/Updates
7.7.6 BioGenex Competitive Strengths & Weaknesses
7.8 Sysmex
7.8.1 Sysmex Details
7.8.2 Sysmex Major Business
7.8.3 Sysmex HER2 Tumor Marker Testing Product and Services
7.8.4 Sysmex HER2 Tumor Marker Testing Revenue, Gross Margin and Market Share (2018-2023)
7.8.5 Sysmex Recent Developments/Updates
7.8.6 Sysmex Competitive Strengths & Weaknesses
7.9 Abnova
7.9.1 Abnova Details
7.9.2 Abnova Major Business
7.9.3 Abnova HER2 Tumor Marker Testing Product and Services
7.9.4 Abnova HER2 Tumor Marker Testing Revenue, Gross Margin and Market Share (2018-2023)
7.9.5 Abnova Recent Developments/Updates
7.9.6 Abnova Competitive Strengths & Weaknesses
7.10 Novartis
7.10.1 Novartis Details
7.10.2 Novartis Major Business
7.10.3 Novartis HER2 Tumor Marker Testing Product and Services
7.10.4 Novartis HER2 Tumor Marker Testing Revenue, Gross Margin and Market Share (2018-2023)
7.10.5 Novartis Recent Developments/Updates
7.10.6 Novartis Competitive Strengths & Weaknesses
7.11 InvivoGen
7.11.1 InvivoGen Details
7.11.2 InvivoGen Major Business
7.11.3 InvivoGen HER2 Tumor Marker Testing Product and Services
7.11.4 InvivoGen HER2 Tumor Marker Testing Revenue, Gross Margin and Market Share (2018-2023)
7.11.5 InvivoGen Recent Developments/Updates
7.11.6 InvivoGen Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 HER2 Tumor Marker Testing Industry Chain
8.2 HER2 Tumor Marker Testing Upstream Analysis
8.3 HER2 Tumor Marker Testing Midstream Analysis
8.4 HER2 Tumor Marker Testing Downstream Analysis
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
1.1 HER2 Tumor Marker Testing Introduction
1.2 World HER2 Tumor Marker Testing Market Size & Forecast (2018 & 2022 & 2029)
1.3 World HER2 Tumor Marker Testing Total Market by Region (by Headquarter Location)
1.3.1 World HER2 Tumor Marker Testing Market Size by Region (2018-2029), (by Headquarter Location)
1.3.2 United States HER2 Tumor Marker Testing Market Size (2018-2029)
1.3.3 China HER2 Tumor Marker Testing Market Size (2018-2029)
1.3.4 Europe HER2 Tumor Marker Testing Market Size (2018-2029)
1.3.5 Japan HER2 Tumor Marker Testing Market Size (2018-2029)
1.3.6 South Korea HER2 Tumor Marker Testing Market Size (2018-2029)
1.3.7 ASEAN HER2 Tumor Marker Testing Market Size (2018-2029)
1.3.8 India HER2 Tumor Marker Testing Market Size (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 HER2 Tumor Marker Testing Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 HER2 Tumor Marker Testing Major Market Trends
2 DEMAND SUMMARY
2.1 World HER2 Tumor Marker Testing Consumption Value (2018-2029)
2.2 World HER2 Tumor Marker Testing Consumption Value by Region
2.2.1 World HER2 Tumor Marker Testing Consumption Value by Region (2018-2023)
2.2.2 World HER2 Tumor Marker Testing Consumption Value Forecast by Region (2024-2029)
2.3 United States HER2 Tumor Marker Testing Consumption Value (2018-2029)
2.4 China HER2 Tumor Marker Testing Consumption Value (2018-2029)
2.5 Europe HER2 Tumor Marker Testing Consumption Value (2018-2029)
2.6 Japan HER2 Tumor Marker Testing Consumption Value (2018-2029)
2.7 South Korea HER2 Tumor Marker Testing Consumption Value (2018-2029)
2.8 ASEAN HER2 Tumor Marker Testing Consumption Value (2018-2029)
2.9 India HER2 Tumor Marker Testing Consumption Value (2018-2029)
3 WORLD HER2 TUMOR MARKER TESTING COMPANIES COMPETITIVE ANALYSIS
3.1 World HER2 Tumor Marker Testing Revenue by Player (2018-2023)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global HER2 Tumor Marker Testing Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for HER2 Tumor Marker Testing in 2022
3.2.3 Global Concentration Ratios (CR8) for HER2 Tumor Marker Testing in 2022
3.3 HER2 Tumor Marker Testing Company Evaluation Quadrant
3.4 HER2 Tumor Marker Testing Market: Overall Company Footprint Analysis
3.4.1 HER2 Tumor Marker Testing Market: Region Footprint
3.4.2 HER2 Tumor Marker Testing Market: Company Product Type Footprint
3.4.3 HER2 Tumor Marker Testing Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers, Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF THE WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: HER2 Tumor Marker Testing Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: HER2 Tumor Marker Testing Market Size Comparison (2018 & 2022 & 2029) (by Headquarter Location)
4.1.2 United States VS China: HER2 Tumor Marker Testing Revenue Market Share Comparison (2018 & 2022 & 2029)
4.2 United States Based Companies VS China Based Companies: HER2 Tumor Marker Testing Consumption Value Comparison
4.2.1 United States VS China: HER2 Tumor Marker Testing Consumption Value Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: HER2 Tumor Marker Testing Consumption Value Market Share Comparison (2018 & 2022 & 2029)
4.3 United States Based HER2 Tumor Marker Testing Companies and Market Share, 2018-2023
4.3.1 United States Based HER2 Tumor Marker Testing Companies, Headquarters (States, Country)
4.3.2 United States Based Companies HER2 Tumor Marker Testing Revenue, (2018-2023)
4.4 China Based Companies HER2 Tumor Marker Testing Revenue and Market Share, 2018-2023
4.4.1 China Based HER2 Tumor Marker Testing Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies HER2 Tumor Marker Testing Revenue, (2018-2023)
4.5 Rest of World Based HER2 Tumor Marker Testing Companies and Market Share, 2018-2023
4.5.1 Rest of World Based HER2 Tumor Marker Testing Companies, Headquarters (States, Country)
4.5.2 Rest of World Based Companies HER2 Tumor Marker Testing Revenue, (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World HER2 Tumor Marker Testing Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Immunohistochemistry (IHC)
5.2.2 Fluorescence In Situ Hybridization (FISH)
5.2.3 Silver In Situ Hybridization (SISH)
5.2.4 Others
5.3 Market Segment by Type
5.3.1 World HER2 Tumor Marker Testing Market Size by Type (2018-2023)
5.3.2 World HER2 Tumor Marker Testing Market Size by Type (2024-2029)
5.3.3 World HER2 Tumor Marker Testing Market Size Market Share by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World HER2 Tumor Marker Testing Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Hospitals
6.2.2 Diagnostic Laboratories
6.2.3 Others
6.3 Market Segment by Application
6.3.1 World HER2 Tumor Marker Testing Market Size by Application (2018-2023)
6.3.2 World HER2 Tumor Marker Testing Market Size by Application (2024-2029)
6.3.3 World HER2 Tumor Marker Testing Market Size by Application (2018-2029)
7 COMPANY PROFILES
7.1 Abbott
7.1.1 Abbott Details
7.1.2 Abbott Major Business
7.1.3 Abbott HER2 Tumor Marker Testing Product and Services
7.1.4 Abbott HER2 Tumor Marker Testing Revenue, Gross Margin and Market Share (2018-2023)
7.1.5 Abbott Recent Developments/Updates
7.1.6 Abbott Competitive Strengths & Weaknesses
7.2 Roche
7.2.1 Roche Details
7.2.2 Roche Major Business
7.2.3 Roche HER2 Tumor Marker Testing Product and Services
7.2.4 Roche HER2 Tumor Marker Testing Revenue, Gross Margin and Market Share (2018-2023)
7.2.5 Roche Recent Developments/Updates
7.2.6 Roche Competitive Strengths & Weaknesses
7.3 Thermo Fisher Scientific
7.3.1 Thermo Fisher Scientific Details
7.3.2 Thermo Fisher Scientific Major Business
7.3.3 Thermo Fisher Scientific HER2 Tumor Marker Testing Product and Services
7.3.4 Thermo Fisher Scientific HER2 Tumor Marker Testing Revenue, Gross Margin and Market Share (2018-2023)
7.3.5 Thermo Fisher Scientific Recent Developments/Updates
7.3.6 Thermo Fisher Scientific Competitive Strengths & Weaknesses
7.4 Agilent
7.4.1 Agilent Details
7.4.2 Agilent Major Business
7.4.3 Agilent HER2 Tumor Marker Testing Product and Services
7.4.4 Agilent HER2 Tumor Marker Testing Revenue, Gross Margin and Market Share (2018-2023)
7.4.5 Agilent Recent Developments/Updates
7.4.6 Agilent Competitive Strengths & Weaknesses
7.5 Leica Biosystems
7.5.1 Leica Biosystems Details
7.5.2 Leica Biosystems Major Business
7.5.3 Leica Biosystems HER2 Tumor Marker Testing Product and Services
7.5.4 Leica Biosystems HER2 Tumor Marker Testing Revenue, Gross Margin and Market Share (2018-2023)
7.5.5 Leica Biosystems Recent Developments/Updates
7.5.6 Leica Biosystems Competitive Strengths & Weaknesses
7.6 Biocare Medical
7.6.1 Biocare Medical Details
7.6.2 Biocare Medical Major Business
7.6.3 Biocare Medical HER2 Tumor Marker Testing Product and Services
7.6.4 Biocare Medical HER2 Tumor Marker Testing Revenue, Gross Margin and Market Share (2018-2023)
7.6.5 Biocare Medical Recent Developments/Updates
7.6.6 Biocare Medical Competitive Strengths & Weaknesses
7.7 BioGenex
7.7.1 BioGenex Details
7.7.2 BioGenex Major Business
7.7.3 BioGenex HER2 Tumor Marker Testing Product and Services
7.7.4 BioGenex HER2 Tumor Marker Testing Revenue, Gross Margin and Market Share (2018-2023)
7.7.5 BioGenex Recent Developments/Updates
7.7.6 BioGenex Competitive Strengths & Weaknesses
7.8 Sysmex
7.8.1 Sysmex Details
7.8.2 Sysmex Major Business
7.8.3 Sysmex HER2 Tumor Marker Testing Product and Services
7.8.4 Sysmex HER2 Tumor Marker Testing Revenue, Gross Margin and Market Share (2018-2023)
7.8.5 Sysmex Recent Developments/Updates
7.8.6 Sysmex Competitive Strengths & Weaknesses
7.9 Abnova
7.9.1 Abnova Details
7.9.2 Abnova Major Business
7.9.3 Abnova HER2 Tumor Marker Testing Product and Services
7.9.4 Abnova HER2 Tumor Marker Testing Revenue, Gross Margin and Market Share (2018-2023)
7.9.5 Abnova Recent Developments/Updates
7.9.6 Abnova Competitive Strengths & Weaknesses
7.10 Novartis
7.10.1 Novartis Details
7.10.2 Novartis Major Business
7.10.3 Novartis HER2 Tumor Marker Testing Product and Services
7.10.4 Novartis HER2 Tumor Marker Testing Revenue, Gross Margin and Market Share (2018-2023)
7.10.5 Novartis Recent Developments/Updates
7.10.6 Novartis Competitive Strengths & Weaknesses
7.11 InvivoGen
7.11.1 InvivoGen Details
7.11.2 InvivoGen Major Business
7.11.3 InvivoGen HER2 Tumor Marker Testing Product and Services
7.11.4 InvivoGen HER2 Tumor Marker Testing Revenue, Gross Margin and Market Share (2018-2023)
7.11.5 InvivoGen Recent Developments/Updates
7.11.6 InvivoGen Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 HER2 Tumor Marker Testing Industry Chain
8.2 HER2 Tumor Marker Testing Upstream Analysis
8.3 HER2 Tumor Marker Testing Midstream Analysis
8.4 HER2 Tumor Marker Testing Downstream Analysis
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
LIST OF TABLES
Table 1. World HER2 Tumor Marker Testing Revenue by Region (2018, 2022 and 2029) & (USD Million), (by Headquarter Location)
Table 2. World HER2 Tumor Marker Testing Revenue by Region (2018-2023) & (USD Million), (by Headquarter Location)
Table 3. World HER2 Tumor Marker Testing Revenue by Region (2024-2029) & (USD Million), (by Headquarter Location)
Table 4. World HER2 Tumor Marker Testing Revenue Market Share by Region (2018-2023), (by Headquarter Location)
Table 5. World HER2 Tumor Marker Testing Revenue Market Share by Region (2024-2029), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World HER2 Tumor Marker Testing Consumption Value Growth Rate Forecast by Region (2018 & 2022 & 2029) & (USD Million)
Table 8. World HER2 Tumor Marker Testing Consumption Value by Region (2018-2023) & (USD Million)
Table 9. World HER2 Tumor Marker Testing Consumption Value Forecast by Region (2024-2029) & (USD Million)
Table 10. World HER2 Tumor Marker Testing Revenue by Player (2018-2023) & (USD Million)
Table 11. Revenue Market Share of Key HER2 Tumor Marker Testing Players in 2022
Table 12. World HER2 Tumor Marker Testing Industry Rank of Major Player, Based on Revenue in 2022
Table 13. Global HER2 Tumor Marker Testing Company Evaluation Quadrant
Table 14. Head Office of Key HER2 Tumor Marker Testing Player
Table 15. HER2 Tumor Marker Testing Market: Company Product Type Footprint
Table 16. HER2 Tumor Marker Testing Market: Company Product Application Footprint
Table 17. HER2 Tumor Marker Testing Mergers & Acquisitions Activity
Table 18. United States VS China HER2 Tumor Marker Testing Market Size Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 19. United States VS China HER2 Tumor Marker Testing Consumption Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 20. United States Based HER2 Tumor Marker Testing Companies, Headquarters (States, Country)
Table 21. United States Based Companies HER2 Tumor Marker Testing Revenue, (2018-2023) & (USD Million)
Table 22. United States Based Companies HER2 Tumor Marker Testing Revenue Market Share (2018-2023)
Table 23. China Based HER2 Tumor Marker Testing Companies, Headquarters (Province, Country)
Table 24. China Based Companies HER2 Tumor Marker Testing Revenue, (2018-2023) & (USD Million)
Table 25. China Based Companies HER2 Tumor Marker Testing Revenue Market Share (2018-2023)
Table 26. Rest of World Based HER2 Tumor Marker Testing Companies, Headquarters (States, Country)
Table 27. Rest of World Based Companies HER2 Tumor Marker Testing Revenue, (2018-2023) & (USD Million)
Table 28. Rest of World Based Companies HER2 Tumor Marker Testing Revenue Market Share (2018-2023)
Table 29. World HER2 Tumor Marker Testing Market Size by Type, (USD Million), 2018 & 2022 & 2029
Table 30. World HER2 Tumor Marker Testing Market Size by Type (2018-2023) & (USD Million)
Table 31. World HER2 Tumor Marker Testing Market Size by Type (2024-2029) & (USD Million)
Table 32. World HER2 Tumor Marker Testing Market Size by Application, (USD Million), 2018 & 2022 & 2029
Table 33. World HER2 Tumor Marker Testing Market Size by Application (2018-2023) & (USD Million)
Table 34. World HER2 Tumor Marker Testing Market Size by Application (2024-2029) & (USD Million)
Table 35. Abbott Basic Information, Area Served and Competitors
Table 36. Abbott Major Business
Table 37. Abbott HER2 Tumor Marker Testing Product and Services
Table 38. Abbott HER2 Tumor Marker Testing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 39. Abbott Recent Developments/Updates
Table 40. Abbott Competitive Strengths & Weaknesses
Table 41. Roche Basic Information, Area Served and Competitors
Table 42. Roche Major Business
Table 43. Roche HER2 Tumor Marker Testing Product and Services
Table 44. Roche HER2 Tumor Marker Testing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 45. Roche Recent Developments/Updates
Table 46. Roche Competitive Strengths & Weaknesses
Table 47. Thermo Fisher Scientific Basic Information, Area Served and Competitors
Table 48. Thermo Fisher Scientific Major Business
Table 49. Thermo Fisher Scientific HER2 Tumor Marker Testing Product and Services
Table 50. Thermo Fisher Scientific HER2 Tumor Marker Testing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 51. Thermo Fisher Scientific Recent Developments/Updates
Table 52. Thermo Fisher Scientific Competitive Strengths & Weaknesses
Table 53. Agilent Basic Information, Area Served and Competitors
Table 54. Agilent Major Business
Table 55. Agilent HER2 Tumor Marker Testing Product and Services
Table 56. Agilent HER2 Tumor Marker Testing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 57. Agilent Recent Developments/Updates
Table 58. Agilent Competitive Strengths & Weaknesses
Table 59. Leica Biosystems Basic Information, Area Served and Competitors
Table 60. Leica Biosystems Major Business
Table 61. Leica Biosystems HER2 Tumor Marker Testing Product and Services
Table 62. Leica Biosystems HER2 Tumor Marker Testing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 63. Leica Biosystems Recent Developments/Updates
Table 64. Leica Biosystems Competitive Strengths & Weaknesses
Table 65. Biocare Medical Basic Information, Area Served and Competitors
Table 66. Biocare Medical Major Business
Table 67. Biocare Medical HER2 Tumor Marker Testing Product and Services
Table 68. Biocare Medical HER2 Tumor Marker Testing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 69. Biocare Medical Recent Developments/Updates
Table 70. Biocare Medical Competitive Strengths & Weaknesses
Table 71. BioGenex Basic Information, Area Served and Competitors
Table 72. BioGenex Major Business
Table 73. BioGenex HER2 Tumor Marker Testing Product and Services
Table 74. BioGenex HER2 Tumor Marker Testing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 75. BioGenex Recent Developments/Updates
Table 76. BioGenex Competitive Strengths & Weaknesses
Table 77. Sysmex Basic Information, Area Served and Competitors
Table 78. Sysmex Major Business
Table 79. Sysmex HER2 Tumor Marker Testing Product and Services
Table 80. Sysmex HER2 Tumor Marker Testing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 81. Sysmex Recent Developments/Updates
Table 82. Sysmex Competitive Strengths & Weaknesses
Table 83. Abnova Basic Information, Area Served and Competitors
Table 84. Abnova Major Business
Table 85. Abnova HER2 Tumor Marker Testing Product and Services
Table 86. Abnova HER2 Tumor Marker Testing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 87. Abnova Recent Developments/Updates
Table 88. Abnova Competitive Strengths & Weaknesses
Table 89. Novartis Basic Information, Area Served and Competitors
Table 90. Novartis Major Business
Table 91. Novartis HER2 Tumor Marker Testing Product and Services
Table 92. Novartis HER2 Tumor Marker Testing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 93. Novartis Recent Developments/Updates
Table 94. InvivoGen Basic Information, Area Served and Competitors
Table 95. InvivoGen Major Business
Table 96. InvivoGen HER2 Tumor Marker Testing Product and Services
Table 97. InvivoGen HER2 Tumor Marker Testing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 98. Global Key Players of HER2 Tumor Marker Testing Upstream (Raw Materials)
Table 99. HER2 Tumor Marker Testing Typical Customers
LIST OF FIGURE
Figure 1. HER2 Tumor Marker Testing Picture
Figure 2. World HER2 Tumor Marker Testing Total Market Size: 2018 & 2022 & 2029, (USD Million)
Figure 3. World HER2 Tumor Marker Testing Total Market Size (2018-2029) & (USD Million)
Figure 4. World HER2 Tumor Marker Testing Revenue Market Share by Region (2018, 2022 and 2029) & (USD Million) , (by Headquarter Location)
Figure 5. World HER2 Tumor Marker Testing Revenue Market Share by Region (2018-2029), (by Headquarter Location)
Figure 6. United States Based Company HER2 Tumor Marker Testing Revenue (2018-2029) & (USD Million)
Figure 7. China Based Company HER2 Tumor Marker Testing Revenue (2018-2029) & (USD Million)
Figure 8. Europe Based Company HER2 Tumor Marker Testing Revenue (2018-2029) & (USD Million)
Figure 9. Japan Based Company HER2 Tumor Marker Testing Revenue (2018-2029) & (USD Million)
Figure 10. South Korea Based Company HER2 Tumor Marker Testing Revenue (2018-2029) & (USD Million)
Figure 11. ASEAN Based Company HER2 Tumor Marker Testing Revenue (2018-2029) & (USD Million)
Figure 12. India Based Company HER2 Tumor Marker Testing Revenue (2018-2029) & (USD Million)
Figure 13. HER2 Tumor Marker Testing Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World HER2 Tumor Marker Testing Consumption Value (2018-2029) & (USD Million)
Figure 16. World HER2 Tumor Marker Testing Consumption Value Market Share by Region (2018-2029)
Figure 17. United States HER2 Tumor Marker Testing Consumption Value (2018-2029) & (USD Million)
Figure 18. China HER2 Tumor Marker Testing Consumption Value (2018-2029) & (USD Million)
Figure 19. Europe HER2 Tumor Marker Testing Consumption Value (2018-2029) & (USD Million)
Figure 20. Japan HER2 Tumor Marker Testing Consumption Value (2018-2029) & (USD Million)
Figure 21. South Korea HER2 Tumor Marker Testing Consumption Value (2018-2029) & (USD Million)
Figure 22. ASEAN HER2 Tumor Marker Testing Consumption Value (2018-2029) & (USD Million)
Figure 23. India HER2 Tumor Marker Testing Consumption Value (2018-2029) & (USD Million)
Figure 24. Producer Shipments of HER2 Tumor Marker Testing by Player Revenue ($MM) and Market Share (%): 2022
Figure 25. Global Four-firm Concentration Ratios (CR4) for HER2 Tumor Marker Testing Markets in 2022
Figure 26. Global Four-firm Concentration Ratios (CR8) for HER2 Tumor Marker Testing Markets in 2022
Figure 27. United States VS China: HER2 Tumor Marker Testing Revenue Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: HER2 Tumor Marker Testing Consumption Value Market Share Comparison (2018 & 2022 & 2029)
Figure 29. World HER2 Tumor Marker Testing Market Size by Type, (USD Million), 2018 & 2022 & 2029
Figure 30. World HER2 Tumor Marker Testing Market Size Market Share by Type in 2022
Figure 31. Immunohistochemistry (IHC)
Figure 32. Fluorescence In Situ Hybridization (FISH)
Figure 33. Silver In Situ Hybridization (SISH)
Figure 34. Others
Figure 35. World HER2 Tumor Marker Testing Market Size Market Share by Type (2018-2029)
Figure 36. World HER2 Tumor Marker Testing Market Size by Application, (USD Million), 2018 & 2022 & 2029
Figure 37. World HER2 Tumor Marker Testing Market Size Market Share by Application in 2022
Figure 38. Hospitals
Figure 39. Diagnostic Laboratories
Figure 40. Others
Figure 41. HER2 Tumor Marker Testing Industrial Chain
Figure 42. Methodology
Figure 43. Research Process and Data Source
Table 1. World HER2 Tumor Marker Testing Revenue by Region (2018, 2022 and 2029) & (USD Million), (by Headquarter Location)
Table 2. World HER2 Tumor Marker Testing Revenue by Region (2018-2023) & (USD Million), (by Headquarter Location)
Table 3. World HER2 Tumor Marker Testing Revenue by Region (2024-2029) & (USD Million), (by Headquarter Location)
Table 4. World HER2 Tumor Marker Testing Revenue Market Share by Region (2018-2023), (by Headquarter Location)
Table 5. World HER2 Tumor Marker Testing Revenue Market Share by Region (2024-2029), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World HER2 Tumor Marker Testing Consumption Value Growth Rate Forecast by Region (2018 & 2022 & 2029) & (USD Million)
Table 8. World HER2 Tumor Marker Testing Consumption Value by Region (2018-2023) & (USD Million)
Table 9. World HER2 Tumor Marker Testing Consumption Value Forecast by Region (2024-2029) & (USD Million)
Table 10. World HER2 Tumor Marker Testing Revenue by Player (2018-2023) & (USD Million)
Table 11. Revenue Market Share of Key HER2 Tumor Marker Testing Players in 2022
Table 12. World HER2 Tumor Marker Testing Industry Rank of Major Player, Based on Revenue in 2022
Table 13. Global HER2 Tumor Marker Testing Company Evaluation Quadrant
Table 14. Head Office of Key HER2 Tumor Marker Testing Player
Table 15. HER2 Tumor Marker Testing Market: Company Product Type Footprint
Table 16. HER2 Tumor Marker Testing Market: Company Product Application Footprint
Table 17. HER2 Tumor Marker Testing Mergers & Acquisitions Activity
Table 18. United States VS China HER2 Tumor Marker Testing Market Size Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 19. United States VS China HER2 Tumor Marker Testing Consumption Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 20. United States Based HER2 Tumor Marker Testing Companies, Headquarters (States, Country)
Table 21. United States Based Companies HER2 Tumor Marker Testing Revenue, (2018-2023) & (USD Million)
Table 22. United States Based Companies HER2 Tumor Marker Testing Revenue Market Share (2018-2023)
Table 23. China Based HER2 Tumor Marker Testing Companies, Headquarters (Province, Country)
Table 24. China Based Companies HER2 Tumor Marker Testing Revenue, (2018-2023) & (USD Million)
Table 25. China Based Companies HER2 Tumor Marker Testing Revenue Market Share (2018-2023)
Table 26. Rest of World Based HER2 Tumor Marker Testing Companies, Headquarters (States, Country)
Table 27. Rest of World Based Companies HER2 Tumor Marker Testing Revenue, (2018-2023) & (USD Million)
Table 28. Rest of World Based Companies HER2 Tumor Marker Testing Revenue Market Share (2018-2023)
Table 29. World HER2 Tumor Marker Testing Market Size by Type, (USD Million), 2018 & 2022 & 2029
Table 30. World HER2 Tumor Marker Testing Market Size by Type (2018-2023) & (USD Million)
Table 31. World HER2 Tumor Marker Testing Market Size by Type (2024-2029) & (USD Million)
Table 32. World HER2 Tumor Marker Testing Market Size by Application, (USD Million), 2018 & 2022 & 2029
Table 33. World HER2 Tumor Marker Testing Market Size by Application (2018-2023) & (USD Million)
Table 34. World HER2 Tumor Marker Testing Market Size by Application (2024-2029) & (USD Million)
Table 35. Abbott Basic Information, Area Served and Competitors
Table 36. Abbott Major Business
Table 37. Abbott HER2 Tumor Marker Testing Product and Services
Table 38. Abbott HER2 Tumor Marker Testing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 39. Abbott Recent Developments/Updates
Table 40. Abbott Competitive Strengths & Weaknesses
Table 41. Roche Basic Information, Area Served and Competitors
Table 42. Roche Major Business
Table 43. Roche HER2 Tumor Marker Testing Product and Services
Table 44. Roche HER2 Tumor Marker Testing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 45. Roche Recent Developments/Updates
Table 46. Roche Competitive Strengths & Weaknesses
Table 47. Thermo Fisher Scientific Basic Information, Area Served and Competitors
Table 48. Thermo Fisher Scientific Major Business
Table 49. Thermo Fisher Scientific HER2 Tumor Marker Testing Product and Services
Table 50. Thermo Fisher Scientific HER2 Tumor Marker Testing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 51. Thermo Fisher Scientific Recent Developments/Updates
Table 52. Thermo Fisher Scientific Competitive Strengths & Weaknesses
Table 53. Agilent Basic Information, Area Served and Competitors
Table 54. Agilent Major Business
Table 55. Agilent HER2 Tumor Marker Testing Product and Services
Table 56. Agilent HER2 Tumor Marker Testing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 57. Agilent Recent Developments/Updates
Table 58. Agilent Competitive Strengths & Weaknesses
Table 59. Leica Biosystems Basic Information, Area Served and Competitors
Table 60. Leica Biosystems Major Business
Table 61. Leica Biosystems HER2 Tumor Marker Testing Product and Services
Table 62. Leica Biosystems HER2 Tumor Marker Testing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 63. Leica Biosystems Recent Developments/Updates
Table 64. Leica Biosystems Competitive Strengths & Weaknesses
Table 65. Biocare Medical Basic Information, Area Served and Competitors
Table 66. Biocare Medical Major Business
Table 67. Biocare Medical HER2 Tumor Marker Testing Product and Services
Table 68. Biocare Medical HER2 Tumor Marker Testing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 69. Biocare Medical Recent Developments/Updates
Table 70. Biocare Medical Competitive Strengths & Weaknesses
Table 71. BioGenex Basic Information, Area Served and Competitors
Table 72. BioGenex Major Business
Table 73. BioGenex HER2 Tumor Marker Testing Product and Services
Table 74. BioGenex HER2 Tumor Marker Testing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 75. BioGenex Recent Developments/Updates
Table 76. BioGenex Competitive Strengths & Weaknesses
Table 77. Sysmex Basic Information, Area Served and Competitors
Table 78. Sysmex Major Business
Table 79. Sysmex HER2 Tumor Marker Testing Product and Services
Table 80. Sysmex HER2 Tumor Marker Testing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 81. Sysmex Recent Developments/Updates
Table 82. Sysmex Competitive Strengths & Weaknesses
Table 83. Abnova Basic Information, Area Served and Competitors
Table 84. Abnova Major Business
Table 85. Abnova HER2 Tumor Marker Testing Product and Services
Table 86. Abnova HER2 Tumor Marker Testing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 87. Abnova Recent Developments/Updates
Table 88. Abnova Competitive Strengths & Weaknesses
Table 89. Novartis Basic Information, Area Served and Competitors
Table 90. Novartis Major Business
Table 91. Novartis HER2 Tumor Marker Testing Product and Services
Table 92. Novartis HER2 Tumor Marker Testing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 93. Novartis Recent Developments/Updates
Table 94. InvivoGen Basic Information, Area Served and Competitors
Table 95. InvivoGen Major Business
Table 96. InvivoGen HER2 Tumor Marker Testing Product and Services
Table 97. InvivoGen HER2 Tumor Marker Testing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 98. Global Key Players of HER2 Tumor Marker Testing Upstream (Raw Materials)
Table 99. HER2 Tumor Marker Testing Typical Customers
LIST OF FIGURE
Figure 1. HER2 Tumor Marker Testing Picture
Figure 2. World HER2 Tumor Marker Testing Total Market Size: 2018 & 2022 & 2029, (USD Million)
Figure 3. World HER2 Tumor Marker Testing Total Market Size (2018-2029) & (USD Million)
Figure 4. World HER2 Tumor Marker Testing Revenue Market Share by Region (2018, 2022 and 2029) & (USD Million) , (by Headquarter Location)
Figure 5. World HER2 Tumor Marker Testing Revenue Market Share by Region (2018-2029), (by Headquarter Location)
Figure 6. United States Based Company HER2 Tumor Marker Testing Revenue (2018-2029) & (USD Million)
Figure 7. China Based Company HER2 Tumor Marker Testing Revenue (2018-2029) & (USD Million)
Figure 8. Europe Based Company HER2 Tumor Marker Testing Revenue (2018-2029) & (USD Million)
Figure 9. Japan Based Company HER2 Tumor Marker Testing Revenue (2018-2029) & (USD Million)
Figure 10. South Korea Based Company HER2 Tumor Marker Testing Revenue (2018-2029) & (USD Million)
Figure 11. ASEAN Based Company HER2 Tumor Marker Testing Revenue (2018-2029) & (USD Million)
Figure 12. India Based Company HER2 Tumor Marker Testing Revenue (2018-2029) & (USD Million)
Figure 13. HER2 Tumor Marker Testing Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World HER2 Tumor Marker Testing Consumption Value (2018-2029) & (USD Million)
Figure 16. World HER2 Tumor Marker Testing Consumption Value Market Share by Region (2018-2029)
Figure 17. United States HER2 Tumor Marker Testing Consumption Value (2018-2029) & (USD Million)
Figure 18. China HER2 Tumor Marker Testing Consumption Value (2018-2029) & (USD Million)
Figure 19. Europe HER2 Tumor Marker Testing Consumption Value (2018-2029) & (USD Million)
Figure 20. Japan HER2 Tumor Marker Testing Consumption Value (2018-2029) & (USD Million)
Figure 21. South Korea HER2 Tumor Marker Testing Consumption Value (2018-2029) & (USD Million)
Figure 22. ASEAN HER2 Tumor Marker Testing Consumption Value (2018-2029) & (USD Million)
Figure 23. India HER2 Tumor Marker Testing Consumption Value (2018-2029) & (USD Million)
Figure 24. Producer Shipments of HER2 Tumor Marker Testing by Player Revenue ($MM) and Market Share (%): 2022
Figure 25. Global Four-firm Concentration Ratios (CR4) for HER2 Tumor Marker Testing Markets in 2022
Figure 26. Global Four-firm Concentration Ratios (CR8) for HER2 Tumor Marker Testing Markets in 2022
Figure 27. United States VS China: HER2 Tumor Marker Testing Revenue Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: HER2 Tumor Marker Testing Consumption Value Market Share Comparison (2018 & 2022 & 2029)
Figure 29. World HER2 Tumor Marker Testing Market Size by Type, (USD Million), 2018 & 2022 & 2029
Figure 30. World HER2 Tumor Marker Testing Market Size Market Share by Type in 2022
Figure 31. Immunohistochemistry (IHC)
Figure 32. Fluorescence In Situ Hybridization (FISH)
Figure 33. Silver In Situ Hybridization (SISH)
Figure 34. Others
Figure 35. World HER2 Tumor Marker Testing Market Size Market Share by Type (2018-2029)
Figure 36. World HER2 Tumor Marker Testing Market Size by Application, (USD Million), 2018 & 2022 & 2029
Figure 37. World HER2 Tumor Marker Testing Market Size Market Share by Application in 2022
Figure 38. Hospitals
Figure 39. Diagnostic Laboratories
Figure 40. Others
Figure 41. HER2 Tumor Marker Testing Industrial Chain
Figure 42. Methodology
Figure 43. Research Process and Data Source
